GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » COGS-to-Revenue

Shanghai Pioneer Holding (HKSE:01345) COGS-to-Revenue : 0.58 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Shanghai Pioneer Holding COGS-to-Revenue?

Shanghai Pioneer Holding's Cost of Goods Sold for the six months ended in Dec. 2023 was HK$523 Mil. Its Revenue for the six months ended in Dec. 2023 was HK$908 Mil.

Shanghai Pioneer Holding's COGS to Revenue for the six months ended in Dec. 2023 was 0.58.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shanghai Pioneer Holding's Gross Margin % for the six months ended in Dec. 2023 was 42.40%.

Shanghai Pioneer Holding COGS-to-Revenue Historical Data

The historical data trend for Shanghai Pioneer Holding's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Pioneer Holding COGS-to-Revenue Chart

Shanghai Pioneer Holding Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.48 0.54 0.46 0.50 0.57

Shanghai Pioneer Holding Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.46 0.53 0.57 0.58

Shanghai Pioneer Holding COGS-to-Revenue Calculation

Shanghai Pioneer Holding's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=982.688 / 1713.594
=0.57

Shanghai Pioneer Holding's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=522.771 / 907.576
=0.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Pioneer Holding  (HKSE:01345) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shanghai Pioneer Holding's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 522.771 / 907.576
=42.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shanghai Pioneer Holding COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shanghai Pioneer Holding's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Pioneer Holding (HKSE:01345) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Shanghai Pioneer Holding Ltd (HKSE:01345) » Definitions » COGS-to-Revenue
Comparable Companies
HKSE:03390 HKSE:01110 HKSE:02211 HKSE:06108 HKSE:00348 WBA BSP:RADL3 HKSE:00241 TSE:3088 SAU:4164 SHSE:603939 TSE:3349 SHSE:600998 HKSE:09885 TSE:3391 TSE:3141 JSE:CLS TSE:9989 TSE:7649 SAU:4163
Traded in Other Exchanges
N/A
Address
No.15, Lane 88 Wuwei Road, Putuo District, Shanghai, CHN, 200331
Website
http://www.pioneer-pharma.com
Shanghai Pioneer Holding Ltd is an investment holding company. It is engaged in the marketing, promotion, sales, and channel management service for pharmaceutical products and medical devices in China. The company has a portfolio of pharmaceutical products, covering ophthalmology, pain management, cardiovascular, gastroenterology, immunology, gynecology, and other therapeutic areas, and medical devices covering several medical specialties, including ophthalmology, orthopedics, odontology, and wound care. The majority of its revenue derives from the Sales of pharmaceutical products segment. The group operates mainly in PRC.
Executives
Bank Of Communications Trustee Limited 2301 Trustee
Pioneer Pharma (bvi) Co.,ltd 2101 Beneficial owner
Tian Tian Limited 2201 Interest of corporation controlled by you
Li Xinzhou 2202 Interest of your spouse
Wu Qian 2201 Interest of corporation controlled by you

Shanghai Pioneer Holding (HKSE:01345) Headlines

No Headlines